Beli, a DTC provider of prenatal vitamins, will likely raise a round of funding of up to $5 million in six to 12 months, CEO Joni Davis tells Axios exclusively.
Why it matters: With sperm health on a multi-decade decline, the startup is part of a growing trend to provide prenatal supplements to men as well as to women.
